Clinical Trial Update: Long-acting G-CSF for Febrile Neutropenia [Phase 3]

View source ↗

Summary

Phase 3 trial update on a long-acting G-CSF for febrile neutropenia in patients with epithelial ovarian cancer; status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Snippet

Sponsor: Lei Li | Conditions: Epithelial Ovarian Cancer, Colony Stimulating Factors | Phase 3 | Status: UNKNOWN